North America Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Market Scenario:

The North America Injectable Drug Delivery Market is accounted to reach USD 354.53 billion by 2024 from USD 154.05 billion in 2016, at a CAGR of 5.4% in the forecast period 2017 to 2024.

The major factors driving the growth of this market are the prevalence of chronic diseases (such as cancer, diabetes, hormonal disorder, and many others), rapidly increasing aging population and the subsequent rise in chronic conditions, rising demand of self-injection devices, technological advancement and innovations in drug delivery market.

Some of the most common chronic diseases include heart disease, stroke, type 2 diabetes, obesity, cancer, and arthritis. According to the Center for Disease Control and Prevention (CDC), in the United States, seven of the top 10 causes of death in 2014 were chronic diseases. Cancer and heart disease together accounted for an approximate of 46% of all deaths. It was also reported that about half of the adults in the United States had one or more chronic conditions and one if four had more than two chronic conditions. Moreover, these numbers are expected to increase in the next 10 years. Since the adoption rate of injectable drug delivery devices is high among the population suffering from diseases like diabetes and heart-related disorders, the increasing prevalence of chronic diseases is expected to contribute to the growth of injectable drug delivery technology market in the forecast period.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/10600

Top Industry Players:
• Pfizer and Baxter International, Inc.,
• Gerresheimer AG,
• Schott AG, Alkermes Plc.,
• Eli Lilly and Company,
• Sandoz,
• Terumo Corporation,
• Teva Pharmaceuticals Industries Ltd.,
• Bespak, Antares Pharma,
• Elcam Medical,
• Haselmeier, Mylan N.V.,
• Novo Nordisk,
• Owen Mumford Ltd,Sanofi,
• West Pharmaceutical Services, Inc,
• Ypsomed Holding AG.

KEY BENEFITS
• An in-depth analysis of various regions would provide a clear understanding of current and future trends so that companies can make region specific plans
• Comprehensive analysis of the factors that drive and restrict the growth of the North America Injectable Drug Delivery market is provided
• Key regulatory guidelines in various regions which impact the North America Injectable Drug Delivery market are critically examined
• Deep dive analysis of various regions provides insights that would enable companies to plan their business moves strategically
• Value chain analysis in the report gives a clear understanding of the roles of the stakeholders involved in the supply chain of the North America Injectable Drug Delivery market.

Request Discount on this repots @ https://marketprognosis.com/discount-request/10600

Market Segments:

The market is further segmented into:
• Type
• Application
• Usage Pattern
• Mode Administration
• End User
• Geography

The North America injectable drug delivery market is segmented on the basis of type, application, usage pattern, mode administration, end user, and distribution channel. The North America injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.
Injectable drug delivery device market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases and other diseases on the basis of application
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.
Based on geography, the North America Injectable Drug Delivery Devices market is segmented into 11 geographical regions, such as,
• U.S.,
• Canada,
• Mexico

Enquiry Before Buying @ https://marketprognosis.com/enquiry/10600

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.